Skip to main content
. 2022 Apr 19;23(9):4473. doi: 10.3390/ijms23094473

Figure 7.

Figure 7

Concentration-dependent effects of subchronic administration of brivaracetam (0, 3 and 10 μM) (A) and levetiracetam (0, 100, and 300 μM) (B) for 7 days on astroglial L-glutamate release induced by subchronic fast-ripple-HFO evoked stimulations (100 set) for 3 or 7 days. Ordinates indicate the mean ± SD of extracellular L-glutamate level (μM) (n = 6). ** p < 0.01; relative to the free of fast-ripple-HFO evoked stimulation (0 days), and @@ p < 0.01; relative to free of brivaracetam or levetiracetam (control) by MANOVA with Tukey’s post-hoc test.